Merck (BUE:MRK) Marketable Securities

: ARS90,972 Mil (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Merck's Marketable Securities for the quarter that ended in Dec. 2023 was ARS90,972 Mil.

Merck's annual Marketable Securities increased from Dec. 2021 (ARS0 Mil) to Dec. 2022 (ARS83,490 Mil) and increased from Dec. 2022 (ARS83,490 Mil) to Dec. 2023 (ARS90,972 Mil).

Merck Marketable Securities Historical Data

The historical data trend for Merck's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

46,264.77

83,489.70

90,972.00

Merck Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Marketable Securities																83,489.70	134,334.00	172,320.00	58,791.60	90,972.00

Merck Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Merck (BUE:MRK) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Merck Marketable Securities Related Terms

Thank you for viewing the detailed overview of Merck's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Merck (BUE:MRK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck & Co Inc (BUE:MRK) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

MRK:USA MRK:Peru MRK:Mexico 1MRKX:Italy 6MKd:UK 0QAH:UK 6MK:Germany MRK:Chile MRCK34:Brazil MRK:Austria

Address

126 East Lincoln Avenue, Rahway, NJ, USA, 07065

Website

https://www.merck.com

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.